Optimized AAV rh.10 Vectors That Partially Evade Neutralizing Antibodies during Hepatic Gene Transfer
Of the 12 common serotypes used for gene delivery applications, Adeno-associated virus (AAV)rh.10 serotype has shown sustained hepatic transduction and has the lowest seropositivity in humans. We have evaluated if further modifications to AAVrh.10 at its phosphodegron like regions or predicted immun...
Saved in:
Main Authors: | Ruchita Selot (Author), Sathyathithan Arumugam (Author), Bertin Mary (Author), Sabna Cheemadan (Author), Giridhara R. Jayandharan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapamycin immune tolerization enables gene transfer following subcutaneous delivery of AAV6 but not CD4-retargeted AAV6 vectors in AAV-seropositive rhesus macaques
by: K. Jerome, et al.
Published: (2019) -
AAV gene therapy vectors in the TMJ
by: Sabine M. Brouxhon, et al.
Published: (2022) -
How long is long-term? Delivery of anti-HIV antibodies using AAV vector
by: J. Martinez-Navio, et al.
Published: (2019) -
Immune responses to AAV vectors, from bench to bedside
by: Hildegard Buning
Published: (2015) -
Evading the Patronage Trap Interest Representation in Mexico
by: Palmer-Rubin, Brian
Published: (2022)